Applied Finance Capital Management, LLC / REGN
Applied Finance Capital Management, LLC’s Regeneron Pharmaceuticals Position
Does Applied Finance Capital Management, LLC own Regeneron Pharmaceuticals (REGN)? Yes — 16.8K shares worth $13M (+0.98% of its 13F portfolio) as of Q1 2026, down from 19.1K shares the prior filed quarter.
Position Value
$13M
Q1 2026
Shares
16.8K
% of Portfolio
+0.98%
Quarters Held
14
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 16.8K | $13M | +0.98% |
| Q4 2025 | 19.1K | $15M | +1.05% |
| Q3 2025 | 22.2K | $12M | +0.89% |
| Q2 2025 | 23.0K | $12M | +0.82% |
| Q1 2025 | 19.8K | $13M | +0.92% |
| Q4 2024 | 28.3K | $20M | +0.88% |
| Q3 2024 | 28.3K | $30M | +1.27% |
| Q2 2024 | 30.2K | $32M | +1.47% |
| Q1 2024 | 22.2K | $21M | +1.50% |
| Q4 2023 | 22.3K | $20M | +1.70% |
| Q3 2023 | 20.5K | $17M | +1.83% |
| Q2 2023 | 18.7K | $13M | +1.53% |
| Q1 2023 | 21.1K | $17M | +2.15% |
| Q4 2022 | 20.9K | $15M | +1.96% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Applied Finance Capital Management, LLC’s full portfolio or all institutional holders of REGN.